Month: October 2018

Three steps to signal detection in Pharmacovigilance

There is a growing emphasis on signal detection and signal management in Pharmacovigilance. Companies must be able to manage signals detected: evaluate them to understand the clinical risk in light of multiple impacting factors, in a demonstrably controlled manner. Benefit/risk balance for a drug, vaccine,

Read More »